Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer

Abstract

Chen Jie, Xu Hong, Chen Yutian. Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer[J]. Journal of International Oncology, 2024, 51(10): 650-654.

References36

[1]	郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3): 221-231. DOI:10.3760/cma.j.cn112152-20240119-00035.
[2]	Herath S, Razavi Bazaz S, Monkman J, et al. Circulating tumor cell clusters: insights into tumour dissemination and metastasis[J].Expert Rev Mol Diagn,2020,20(11): 1139-1147. DOI:10.1080/14737159.2020.1846523. pmid:33140979
[3]	Doglioni G, Parik S, Fendt SM. Interactions in the (Pre)metastatic niche support metastasis formation[J].Front Oncol,2019,9: 219. DOI:10.3389/fonc.2019.00219. pmid:31069166
[4]	Titu S, Gata VA, Decea RM, et al. Exosomes in colorectal cancer: from physiology to clinical applications[J].Int J Mol Sci,2023,24(5): 4382. DOI:10.3390/ijms24054382.
[5]	Liu C, Xia C, Xia C. Biology and function of exosomes in tumor immunotherapy[J].Biomed Pharmacother,2023,169: 115853. DOI:10.1016/j.biopha.2023.115853.
[6]	Tian Y, Cheng C, Wei Y, et al. The role of exosomes in inflammatory diseases and tumor-related inflammation[J].Cells,2022,11(6): 1005. DOI:10.3390/cells11061005.
[7]	Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis[J].Nature,2015,527(7578): 329-335. DOI:10.1038/nature15756.
[8]	Li S, Qu Y, Liu L, et al. Tumour-derived exosomes in liver metastasis: a pandora's box[J].Cell Prolif,2023,56(10): e13452. DOI:10.1111/cpr.13452.
[9]	Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation[J].Nat Commun,2020,11(1): 1211. DOI:10.1038/s41467-020-14869-x. pmid:32139701
[10]	Wang C, Tsai S. Regulation of lymphangiogenesis by extracellular vesicles in cancer metastasis[J].Exp Biol Med (Maywood),2021,246(19): 2048-2056. DOI:10.1177/15353702211021022.
[11]	Sun B, Zhou Y, Fang Y, et al. Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes[J].Int J Cancer,2019,145(6): 1648-1659. DOI:10.1002/ijc.32196. pmid:30734278
[12]	Hu H, Yu C, Zhang H, et al. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2[J].Int J Biol Macromol,2019,132: 470-477. DOI:10.1016/j.ijbiomac.2019.03.221.
[13]	He Q, Ye A, Ye W, et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1[J].Cell Death Dis,2021,12(6): 576. DOI:10.1038/s41419-021-03803-8. pmid:34088891
[14]	Dokhanchi M, Pakravan K, Zareian S, et al. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3[J].Life Sci,2021,285: 119937. DOI:10.1016/j.lfs.2021.119937.
[15]	Shang A, Wang X, Gu C, et al. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1[J].Aging (Albany NY),2020,12(9): 8352-8371. DOI:10.18632/aging.103145.
[16]	Chen C, Liu Y, Liu L, et al. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway[J].J Exp Clin Cancer Res,2023,42(1): 46. DOI:10.1186/s13046-023-02619-y. pmid:36793126
[17]	Hu G, Lin C, Gao K, et al. Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating Smad2/3 pathway in colorectal cancer[J].Mol Med,2023,29(1): 155. DOI:10.1186/s10020-023-00747-x. pmid:37940881
[18]	Li Y, Jiang D, Zhang Z, et al. Colorectal cancer cell-secreted exosomal miRNA N-72 promotes tumor angiogenesis by targeting CLDN18[J].Am J Cancer Res,2023,13(8): 3482-3499. pmid:37693144
[19]	Dou R, Liu K, Yang C, et al. EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer[J].Clin Transl Med,2021,11(12): e595. DOI:10.1002/ctm2.595. pmid:34936736
[20]	Jiang K, Chen H, Fang Y, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness[J].J Exp Clin Cancer Res,2021,40(1): 21. DOI:10.1186/s13046-020-01816-3. pmid:33413536
[21]	Zhao S, Mi Y, Guan B, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer[J].J Hematol Oncol,2020,13(1): 156. DOI:10.1186/s13045-020-00991-2.
[22]	Chen C, Yao X, Xu Y, et al. Dahuang zhechong pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche[J].J Ethnopharmacol,2019,238: 111878. DOI:10.1016/j.jep.2019.111878.
[23]	Liang Z, Liu H, Wang F, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J].Cell Death Dis,2019,10(11): 829. DOI:10.1038/s41419-019-2077-0.
[24]	Wang D, Wang X, Si M, et al. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J].Cancer Lett,2020,474: 36-52. DOI:10.1016/j.canlet.2020.01.005. pmid:31931030
[25]	Pei W, Wei K, Wu Y, et al. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization[J].Gene,2023,885: 147692. DOI:10.1016/j.gene.2023.147692.
[26]	Furumaya C, Martinez-Sanz P, Bouti P, et al. Plasticity in pro- and anti-tumor activity of neutrophils: shifting the balance[J].Front Immunol,2020,11: 2100. DOI:10.3389/fimmu.2020.02100. pmid:32983165
[27]	Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis[J].Mol Cancer,2020,19(1): 117. DOI:10.1186/s12943-020-01235-0.
[28]	Sun H, Meng Q, Shi C, et al. Hypoxia-inducible exosomes facilitate liver-tropic premetastatic niche in colorectal cancer[J].Hepatology,2021,74(5): 2633-2651. DOI:10.1002/hep.32009.
[29]	Huang Y, Luo Y, Ou W, et al. Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC[J].Cancer Cell Int,2021,21(1): 528. DOI:10.1186/s12935-021-02221-2. pmid:34641864
[30]	Hu X, Lin Z, Wang Z, et al. Emerging role of PD-L1 modification in cancer immunotherapy[J].Am J Cancer Res,2021,11(8): 3832-3840. pmid:34522452
[31]	Xian D, Niu L, Zeng J, et al. LncRNA KCNQ1OT1 secreted by tumor cell-derived exosomes mediates immune escape in colorectal cancer by regulating PD-L1 ubiquitination via miR-30a-5p/USP22[J].Front Cell Dev Biol,2021,9: 653808. DOI:10.3389/fcell.2021.653808.
[32]	Sun W, Cui J, Ge Y, et al. Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1[J].Cell Death Discov,2022,8(1): 223. DOI:10.1038/s41420-022-00919-4. pmid:35461336
[33]	Poggio M, Hu TY, Pai CC, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory[J].Cell,2019,177(2): 414-427.e13. DOI:10.1016/j.cell.2019.02.016. pmid:30951669
[34]	Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments[J].Mol Cancer,2023,22(1): 48. DOI:10.1186/s12943-023-01744-8. pmid:36906534
[35]	Tian F, Wang P, Lin D, et al. Exosome-delivered miR-221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer[J].Cancer Sci,2021,112(9): 3744-3755. DOI:10.1111/cas.15028.
[36]	Kamerkar S, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity[J].Sci Adv,2022,8(7): eabj7002. DOI:10.1126/sciadv.abj7002.

Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References36

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Wei Wei, Cai Zhaoying, Qian Yayun.Effect of Marsdenia tenacissima combined with XELOX solution on disulfide apoptosis in human colorectal cancer HCT116 cells[J]. Journal of International Oncology, 2024, 51(9): 545-555.
[2]	Zhan Haifeng, Wang Wenxue, Geng Jiawei.Research progress in precise molecular targeted therapy for advanced colorectal cancer[J]. Journal of International Oncology, 2024, 51(9): 601-605.
[3]	Li Zhiwei, Zhai Chunbao.Research progress on the anti-cancer effect of traditional Chinese medicine polyphenols on colorectal cancer[J]. Journal of International Oncology, 2024, 51(8): 526-531.
[4]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[5]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[6]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[7]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[8]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.
[9]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[10]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[11]	Liu Bohan, Huang Junxing.Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108.
[12]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[13]	He Peipei, Yang Chaofeng, Li Yang.Research status and prospect of tumor microenvironment and ablation therapy for liver cancer[J]. Journal of International Oncology, 2024, 51(10): 655-659.
[14]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.Research progress of myeloid-derived suppressor cells in tumor angiogenesis[J]. Journal of International Oncology, 2024, 51(1): 50-54.
[15]	Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer： present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58.